CENTREX INC
10SB12G, EX-6.3, 2000-11-27
Previous: CENTREX INC, 10SB12G, EX-6.2, 2000-11-27
Next: CENTREX INC, 10SB12G, EX-6.4, 2000-11-27





                               FUNDS-IN AGREEMENT
                     REGENTS OF THE UNIVERSITY OF CALIFORNIA
                         LOS ALAMOS NATIONAL LABORATORY

  Operating Under Prime Contract No. W-74-5-ENG-36 for the U.S. Department of
                      Energy And Sponsor Identified Below

                                    Section I
--------------------------------------------------------------------------------
1.  SPONSOR NAME                                 2.  FUNDS-IN AGREEMENT NUMBER
E. coli Measurement Systems, Inc.                FIA-98-053
--------------------------------------------------------------------------------
3.  ESTIMATED PERFORMANCE                        4.  PROJECT TITLE/DESCRIPTION
    PERIOD (IN MONTHS)
24 Months                                        Prototype System for Detection
                                                 of Bacterial Contamination
--------------------------------------------------------------------------------

5.  FINANCIAL                                    6.  LOS ALAMOS NATIONAL
a.       Estimated Cost                              LABORATORY
     (1)  LANL Cost         $410,000             a. Technical Representative:
     (2)  Total Cost to                             Alonso Castro
          Sponsor           $410,000                Los Alamos National
                                                     Laboratory
                                                    P.O. Box 1663, P-21, MS D434
b.    Incremental Funding                           Los Alamos, NM 87545
      Approved                  Yes                 Telephone: (505) 665-8044
c.    Amount Advanced                               Fax: (505) 667-1112
      This Action            $70,000                E-Mail:  [email protected]

See Attached Invoice for Advance Payment Instructions
--------------------------------------------------------------------------------
7.  AGREEMENT TERMS AND CONDITIONS
This  Agreement  consists  of this  form  with  Terms  and  Conditions  plus the
following:
a.  Appendix A - Statement of Work       c. Appendix C - Rights in Technical
    Facilities                              Data - Use of
b.  Appendix B - Patent Rights
     - Use of Facilities                 (Unlimited)
                                         d.  Other:
--------------------------------------------------------------------------------
8.  FOR E.COLI MEASUREMENT              9.  FOR THE REGENTS OF THE
    SYSTEMS, INC.                           UNIVERSITY OF CALIFORNIA
--------------------------------------------------------------------------------
Name:   Dr. Clifford M. Gross           Name:   Dr. Donna M. Smith
Title:  President                       Title:  Program Manager
Address:202 South Wheeler Street        Address:Los Alamos National Laboratory
        Plant City  FL  33566                   Civilian and Industrial
                                                Technology Programs
                                                Partnership Agreements Office
                                                P.O. Box 1663, MS C334
                                                Los Alamos, NM  87545

--------------------------------------------------------------------------------
Telephone: (813) 654-6113               Telephone: (505) 667-9473
Fax: (813) 754-2383                     Fax: (505) 667-0603
--------------------------------------------------------------------------------
Signature        Date                   Signature                  Date


--------------------------------------------------------------------------------
                              TERMS AND CONDITIONS
                                   Section II
--------------------------------------------------------------------------------
1. Parties to the  Agreement.  The U.S.  Department  of Energy  Contractor,  The
Regents  of  the  University  of  California,  hereinafter  referred  to as  the
"University",  has been  requested by the Sponsor  referred to in Section  I.1.,
hereinafter  referred to as the "Sponsor",  to perform the work set forth in the
Statement  of Work,  attached  hereto as  Appendix  A. It is  understood  by the
Parties that the University is obligated to comply with the terms and conditions
of  its  Management  and  Operations  (M&O)  contract  with  the  United  States
Government  (hereinafter  called  the  "government")  represented  by the United
States Department of Energy  (hereinafter called the "Department" or "DOE") when
providing goods, services, products, processes, materials, or information to the
Sponsor under this Agreement.

2. Term of the  Agreement.  This  Agreement  shall be effective as of the latter
date of (1) the date on which it is signed by the last of the  Parties  thereto,
or (2) the  date on which  the  University  receives  advance  funding  from the
sponsor,  and shall continue for the estimated period stated in Section I.3. The
term of this  Agreement  may be extended  by mutual,  written  agreement  of the
Parties when the extension does not affect the cost,  statement of work or terms
and conditions, which require a formal amendment to this Agreement.
--------------------------------------------------------------------------------


                                                   Sequentially numbered page 99
<PAGE>



--------------------------------------------------------------------------------
3. Costs.  The University has no obligation to continue or complete  performance
of the work at a cost stated in Section l.5.(2) in excess of its estimated cost,
including any subsequent  amendment.  The University  agrees to provide at least
thirty (30) days notice to the Sponsor if it is anticipated that the actual cost
to complete performance will exceed its estimated cost.

4. Funding and Payment.  The  University  is required by DOE to receive  advance
funding before  beginning  work. The Sponsor shall provide  sufficient  funds in
advance to reimburse the  University  for costs to be incurred in performance of
the  work  described  in  this  Agreement,  and  the  University  shall  have no
obligation to perform in the absence of adequate advance funds. If the estimated
period of  performance  exceeds  ninety (90) days or the estimated  cost exceeds
$25,000,  the  Sponsor  may,  with  the  University's  approval,  advance  funds
incrementally  In such a case, the University may initially  invoice the Sponsor
in an amount  sufficient  to permit the work to proceed for one  hundred  twenty
(120)  days,  and  thereafter  invoice  the  Sponsor  monthly so as to  maintain
approximately a ninety (90) day period that is funded in advance,  Payment shall
be made directly to the University. Upon termination or completion, excess funds
shalt be refunded by the  University  to the  Sponsor,  in  accordance  with the
University's closeout procedures.

5. Source of Funds. If the Sponsor is receiving funding from another  Government
source,  this  Agreement  does  not  serve  to  release  the  Sponsor  from  any
obligations  it has  under  the  Agreement  with the  Government  providing  the
funding.

6. Property. Upon termination of this Agreement,  property or equipment having a
value  greater than $25,000  produced or acquired in  conducting  the work under
this Agreement shall be owned as follows:

Property  valued over  $25,000  disposed of as  directed  by the  Sponsor,  with
property  under  $25,000 to remain at Los  Alamos  National  Laboratory,  and to
become property of the Government,  unless otherwise  specified in the Statement
of Work.  No Federal  funds will be used to purchase  property or equipment  for
this  Agreement.  Property  or  equipment  produced  or acquired as part of this
Agreement will be accounted for and maintained during the term of this Agreement
in the same manner as  Department  property or  equipment.  Any  property  which
becomes integrated into the Facility becomes the property of the Government.

7. Pre-Publication  Review. The publishing Party shall provide the other Party a
sixty (60) day period in which to review and comment on  proposed  publications,
including  news  releases and  advertisements,  that either  disclose  technical
developments and/or research findings generated in the course of this Agreement,
or identify Proprietary  Information.  The publishing Party shall not publish or
otherwise disclose  Proprietary  Information or Protected Generated  Information
identified by the other Party, except as provided by law.

8. Legal Notice. Any technical paper,  article  publication,  or announcement of
advances generated in connection with the work done under this Agreement, during
the period of  performance  of this Agreement or in the future shall give credit
to the Sponsor as a sponsor of the work and shall contain the following notice:

THIS REPORT WAS PREPARED AS AN ACCOUNT OF WORK UNDER A SPONSORED  AGREEMENT  AND
PURSUANT TO CONTRACT  BETWEEN THE UNIVERSITY  AND THE UNITED STATES  GOVERNMENT.
NEITHER THE UNITED STATES  GOVERNMENT,  THE UNITED STATES  DEPARTMENT OF ENERGY,
NOR THE REGENTS OF THE  UNIVERSITY  OF  CALIFORNIA,  NOR ANY OF THEIR  EMPLOYEES
MAKES ANY  WARRANTY,  EXPRESSED  OR IMPLIED,  OR ASSUMES ANY LEGAL  LIABILITY OR
RESPONSIBILITY   FOR  THE   ACCURACY,   COMPLETENESS,   OR   USEFULNESS  OF  ANY
INFOIIMIATION,  APPARATUS, PRODUCT, OR PROCESS DISCLOSED, OR REPRESENTS THAT ITS
USE WOULD NOT INFRINGE PRIVATELY OWNED RIGHTS.  REFERENCE HEREIN TO ANY SPECIFIC
COMMERCIAL PRODUCT,  PROCESS, OR SERVICE BY TRADE NAME, MARK,  MANUFACTURER,  OR
OTHERWISE,   DOES  NOT   NECESSARILY   CONSTITUTE  OR  IMPLY  ITS   ENDORSEMENT,
RECOMMENDAT[ON,  OR FAVORING BY THE UNITED  STATES  GOVERNMENT  OR ANY AGENCY OR
CONTRACTOR  THEREOF.  THE VIEWS AND OPINIONS OF AUTHORS  EXPRESSED HEREIN DO NOT
NECESSARILY STATE OR REFLECT THOSE OF THE UNITED STATES GOVERNMENT OR ANY AGENCY
OR CONTRACTOR THEREOF.

                                                  Sequentially numbered page 100
<PAGE>


9.  Disclaimer.  THE  GOVERNMENT,  AND THE UNIVERSITY MAKE NO EXPRESS OR IMPLIED
WARRANTY AS TO THE  CONDITIONS  OF THE  RESEARCH OR ANY  INTELLECTUAL  PROPERTY,
GENERATED  INFORMATION,  OR PRODUCT MADE, OR DEVELOPED UNDER THIS AGREEMENT,  OR
THE  OWNERSHIP,  MERCHANTABILITY  OR  FITNESS  FOR A  PARTICULAR  PURPOSE OF THE
RESEARCH OR RESULTING PRODUCT. NEITHER THE GOVERNMENT,  NOR THE UNIVERSITY SHALL
BE LIABLE FOR SPECIAL,  CONSEQUENTIAL OR INCIDENTAL  DAMAGES  ATTRIBUTED TO SUCH
RESEARCH OR RESULTING PRODUCT,  INTELLECTUAL PROPERTY, GENERATED INFORMATION, OR
PRODUCT MADE, OR DEVELOPED UNDER THIS AGREEMENT.

10.a Product  Liability  Indemnity.  The Sponsor  hereby agrees to indemnify and
hold harmless the University,  and the Government,  their officers,  agents, and
employees,  from any and all liability,  claims or damages,  including  attorney
fees and cost  whatsoever,  for injury to or death of  persons,  or damage to or
destruction of property,  as a result of or arising out of the making, using, or
selling  of a  product,  process,  or service  which was  derived  from the work
performed under this Agreement by or on behalf of the Sponsor,  its assignees or
licensees,  provided,  however,  that neither the  Government nor the University
shall be  considered  assignees  or  licensees  of the  Sponsor  as a result  of
reserved Government and University rights.

10.b General  Indemnity.  Except for any liability  resulting from any negligent
acts or omissions of the University,  the Sponsor hereby agrees to indemnif~ and
hold harmless the University and the  Government,  their officers,  agents,  and
employees from any and all liability, claims or damages, including attorney fees
and cost  whatsoever,  for  injury  to or  death of  persons,  or  damage  to or
destruction  of property  arising out of the  performance of the work under this
agreement.

11.  Intellectual  Property Indemnity - Limited.  The Sponsor shah indemnify the
Government and the University, and their officers, agents, and employees against
liability,  including  attorney's fees and costs, for infringement of any United
States patent, copyright, or other intellectual property arising out of any acts
required or directed by the Sponsor to be performed under this Agreement, to the
extent such acts are not already performed at the Facility. Such indemnity shall
not apply to a claimed  infringement  that is settled without the consent of the
Sponsor unless required by a court of competent jurisdiction.

12.  Notice and  Assistance  Regarding  patent and Copyright  Infringement.  The
Sponsor  shall report to the  Department  and the  University  promptly,  and in
reasonable written detail, each claim of patent or copyright  infringement based
on the  performance of this  Agreement of which the Sponsor has  knowledge.  The
Sponsor shall furnish to the  Department and the  University,  when requested by
the Department or the University, all evidence and information in the possession
of the Sponsor pertaining to such claim.

13. Patents and Technical Data Rights.  Terms and Conditions  regarding  Patents
and  Technical  Data Rights are set forth in the attached here as Appendix B and
Appendix C, respectively.

14.  Assignment.  Neither this  Agreement,  nor any interest  therein,  or claim
thereunder  shall  be  assigned  or  transferred  by  either  Party,  except  as
authorized  in  writing  by the  other  Party to this  Agreement,  provided  the
University may transfer it to the  Department,  or its designee,  with notice of
such  transfer  to the  Sponsor,  and  the  University  shall  have  no  further
responsibilities  except for the  confidentiality,  use,  and/or  non-disclosure
obligations of this Agreement.

15. Similar or Identical  Services.  The Government and/or University shall have
the right to perform  similar or  identical  services in the  Statement  of Work
(SOW) for other Sponsors, as long as neither Sponsor's  Proprietary  Information
nor Protected Information during the term of its protection is utilized.

16. Non  Competition.  The Sponsor  states  that,  to the best of the  Sponsor's
knowledge,  the  University  is not in  competition  with the  domestic  private
sector.

17. Export  Control.  Each party is responsible for its own compliance with laws
and regulations governing export controls.


                                                  Sequentially numbered page 101
<PAGE>


18.  Termination.  Performance of work under this Agreement may be terminated at
any time by either  Party,  without  liability,  upon  giving a thirty  (30) day
written notice to the other Party. The University shall terminate this Agreement
only  when the  University  determines,  after  direction  from  DOE,  that such
termination is in the best interest of the Government,  provided  however,  that
the  University  shall have the right to  terminate  if the  Sponsor  shall have
failed to advance the funds required by article 4., Funding and Payment.  In the
event of termination the Sponsor shall be responsible for the University's costs
(including closeout costs), through the effective date of termination, but in no
event  shall the  Sponsor's  cost  responsibility  exceed  the total cost to the
Sponsor as described in Section I. (5) Financial.

19. Entire Agreement and Amendments to the Agreement. It is expressly understood
and agreed that this Agreement with its Appendices contains the entire Agreement
between the Parties.  Any  agreement to change any terms and  conditions of this
Agreement or the Appendices shall be valid only if the change is made in writing
and executed by the Parties to this Agreement.

20. Force  Majeure.  No failure or omission by the  University or Sponsor in the
performance of any obligation  under this Agreement  shall be deemed a breach of
this Agreement or create any liability if the same shall arise from any cause or
causes  beyond the  control of the  University  or  Sponsor,  including  but not
limited to the following,  which,  for the purpose of this  Agreement,  shall be
regarded as beyond the control of the Party in  question:  Acts of God,  acts or
omissions of any government or agency  thereof,  compliance  with  requirements,
rules,  regulations,  or orders of any  governmental  authority,  or any office,
department,  agency, or instrumentality thereof, fire, storm, flood, earthquake,
accident,  acts  of  the  public  enemy,  war,  rebellion,  insurrection,  riot,
sabotage,  invasion,  quarantine,  restriction,   transportation  embargoes,  or
failures or delays in transportation.

                                                  Sequentially numbered page 102
<PAGE>


                                   APPENDIX A
                                Statement of Work
                                   FIA-98-053
                        E. coli Measurement Systems, Inc.
            Prototype System for Detection of Bacterial Contamination

I. Description of Services

   1.0   Objective
         It is  widely  accepted  that  current  methods  for  the  analysis  of
         bacterial   contamination  in  food  products  are  inadequate.   These
         traditional  methods  rely  on  enrichment  regimes  and  isolation  on
         diagnostic plates followed by biochemical tests, sometimes with further
         characterization by  serology/diagnostic  media. These methods can take
         many days to give  results,  which is an  unacceptable  amount of time,
         particularly  when  dealing  with  perishable  items like foods.  Thus,
         corrective  action to combat any safety or spoilage  problems cannot be
         implemented immediately. The methods are also labor intensive and hence
         costly,   and  the  quality  of  the  information   provided  is  often
         questionable.  These  methods  are  also  incapable  of  detecting  the
         so-called  "viable but  not-culturable  cells" whose  significance  for
         quality control of food products is as yet uncertain.  New methods need
         to be developed  which should  ideally be able to:
          a) Give results in a short period of time (< 1 hr).
          b)  Be  highly   sensitive,   reproducible  and  repeatable,   and  be
          non-hazardous  (i.e.,  radio-isotopes  are not  acceptable in the food
          handling environment).
          c) Not interfered with by the presence of other organisms.
          d) Give  accurate and reliable  information  about the identity of the
          pathogen.
          e) Be applicable to a wide range of organisms.
          f) Have a low per-assay cost.
          g) Be amenable to automation.
         We propose to develop methods and instrumentation for the detection and
         quantitation  of  bacterial   contaminants  present  in  food  products
         according to the criteria  outlined above. This new technique makes use
         of newly devised  molecular biology protocols for the direct and highly
         specific   detection  of  characteristic   nucleic  acid  sequences  of
         pathogens  present in food  samples.  A highly  sensitive  fluorescence
         detector  based  on  our  demonstrated   technique  of  single-molecule
         detection  will be  developed  to identify  the  presence of  low-level
         nucleic  acids.  The new method  described here promises to combine the
         advantages of flow-based analytical Systems (system automation,  speed,
         reproducibility)  with the unsurpassed  sensitivity of  single-molecule
         detection.  The  sensitivity  of this  method  allows  for  the  direct
         detection of specific  pathogenic  nucleic  acids  without the need for
         using  amplification  methods such as PCR and exhibits  advantages over
         current methodologies in terms of sensitivity,  specificity, speed, and
         per-assay-cost.

   2.0   Scope
         This project will be divide in two phases.  The initial phase  consists
         of  developing  the  necessary  molecular  biology  protocols  for  the
         detection of specific  nucleic acid sequences with high sensitivity and
         specificity.  The method consists of synthesizing a highly  fluorescent
         nucleic  acid  reporter  molecule  using a sequence  of the target as a
         template.   This   synthesis   is   accomplished   by   using  a  short
         oligonucleotide  primer that is complementary to the target. A suitable
         polymerize and free  nucleotides are added to the sample.  One of these
         oligonucleotides is -at least partially- labeled with a fluorophore. If
         the target is present in the  sample,  the primer  binds to it, and the
         polymerase  will  incorporate  the  labeled and  unlabeled  nucleotides
         reconstructing  the  target's  complementary  sequence.  If the labeled
         nucleotide   concentration   is  kept  below  that  of  the   unlabeled
         nucleotides,  most of it will be  incorporated  into the  reporter  DNA
         molecule.  Detection  of the  reporter  signifies  the  presence of the
         target being sought.  The fluorescent signal from the reporter molecule
         is expected to be much larger than that of the  background  originating
         from free labeled nucleotides, since the reaction is allowed to proceed
         until the  reporter  molecule is hundreds or  thousands  of bases long.
         Initially,  lambda  DNA  will  be  used  as  a  model  system  for  all
         experiments.  Once the  protocols  are  fully  developed,  they will be
         optimized for the detection of E. coli. The second phase of the project
         consists of designing and constructing an ultra sensitive  fluorescence
         detector   prototype.   This   instrument   will   be   based   on  our
         single-molecule  detection technology,  and will allow the detection of
         reporter   molecules   described   above  with  high   specificity  and
         single-molecule sensitivity. The total project duration is 24 months.

                                                  Sequentially numbered page 103
<PAGE>





   3.0   Applicable Documents
         S-89, 696 --> Castro, METHOD FOR THE DETECTION OF SPECIFIC NUCLEIC ACID
         SEQUENCES  BY   POLYMERASE   NUCLEOTIDE   INCORPORATION.   UC  filed  a
         provisional patent  application  12/18/98 and elected title in the name
         of UC. Foreign filing rights may be applied for on this technology. The
         technology has not yet been reduced to practice.  The technology is not
         encumbered at this time, so it is presently available for licensing.

<TABLE>
<CAPTION>


4.0      Technical Tasks
          <S>          <C>                              <C>                                   <C>           <C>

         Phase        Task                             Description                             Start      Duration
                                                                                               Month      (Months)
         I                      Development of molecular biology protocols.
                      1         Nucleic acid probe design.  Optimal E. coli and lambda      1            1
                                nucleic acid sequences will be determined for maximum
                                specificity.
                      2         Optimization of protocols for labeled nucleotide            2            6
                                incorporation by polymerize target extension.  Labeled
                                oligonucleotides complementary to nucleic acid targets
                                will be synthesized by enzymatic extension reactions.
                                Optimal conditions for fluorescent report synthesis
                                will be determined.
                      3         Optimization of sample preparation protocols.               8            3
                                Experiments will be performed to determine the optimal
                                conditions for sample preparation.  Various parameters
                                such as buffer composition, extraction procedures, and
                                hybridization conditions will be evaluated.  Targets will
                                consist of low levels of E. coli genomic DNA.  Effects of
                                interferants usually present in food samples will be
                                evaluated.
                      4         Demonstration of the detection of specific sequences of     11           2
                                bacterial contaminants.  The detection system currently
                                in operation at LANL will be modified to perform
                                experiments on the detection of specific sequences of
                                bacterial contaminants.  Increasingly diluted samples
                                of   E. coli genomic DNA will be analyzed.  Limits of
                                detection are expected to lie in the femtomolar (10-15
                                M) range.
         II                     Design and construction of a prototype instrument for the   13
                                detection of low levels of E. coli.
                      1         Prototype design.  This instrument will be composed of      13           1
                                various subsystems: optical, sample delivery,
                                electronics, data acquisition and automated control.  At
                                this stage , these subsystems will be designed in
                                accordance to the molecular biology protocols
                                developed in Phase I.  Each component will be specified.
                      2         Constuction of optical subsystem.  The                      14           3
                                high-collection-efficiency fluorescence detection optical
                                subsystem will  be constructed.  This subsystem consists
                                of excitation componenets (laser, focusing optics),
                                fluorescence collection optical components, spectral and
                                spatial discrimination components, and single-photom
                                detection components, in accordance to established single-
                                molecule detection technology.

</TABLE>

                                                  Sequentially numbered page 104
<PAGE>

<TABLE>
<CAPTION>

   4.0   Technical Tasks (continued)

                     <S>                             <C>                                   <C>          <C>

                      3         Construction of sample delivery subsystem.  The automated   17           2
                                internal sample injection subsystem will be constructed.
                                It consists of a fluorescence micro-cell and sample
                                injection components.
                      4         Construction of electronics subsystem.  This subsystem      19           1
                                comprises the signal amplification and conditioning
                                electronics, scaling electronics, computer interface
                                electronics, and power supplies for various electronic
                                components.
                      5         Implementation of data acquisition and automated            20           3
                                control subsystem.  In this stage, the data acquisition
                                and automated control software will be written in the
                                LabVIEW programming environment.
                      6         Final system integration and test.  The electronics and     23           2
                                optical subsystems will be incorporated into an
                                instrument chassis at this point.  The limits of detection
                                of the instrument will be determined by detecting
                                increasingly smaller quantities of E. coli genomic DNA.
</TABLE>


II.      Reports Data and Other Deliverables
   A prototype  instrument for the detection of food pathogens will be delivered
to the company.

III.     Special Considerations
   None.

IV.      Designated Signature Authorities/Representatives


   E. coli Measurement Systems, Inc.         Los Alamos National Laboratory
   Attn.:Dr. Clifford M. Gross               Attn.: Ms. Lucille A. Peralta
   President                                 Civilian and Industrial Technology
   202 South Wheeler Street                     Programs
   Plant City FL 33566                       Partnership Agreements Office
                                             Los Alamos National Laboratory
                                             P.O. Box 1663, MS C334
   Tel:   (8l3) 654-6l13                     Los Alamos, NM 87545
   Fax:   (813) 754-2383                     Tel:  (505) 665-6711
                                             Fax:  (505) 665-6127



                                                  Sequentially numbered page 105
<PAGE>






                                   APPENDIX B
                       PATENTS RIGIITS - USE OF FACILITIES

1. Definitions.

     A.   "Invention"  means  any  invention  or  discovery  which  is or may be
          patentable  or  otherwise  protectable  under  Title 35 of the  United
          States  Code  or  any  novel  variety  of  plant  that  is or  may  be
          protectable under the Plant Variety Protection Action (7 U.S.C. 232 et
          seq.).

     B.   "Sponsor  Invention"  means  any  invention,  to the  extent  that the
          Sponsor is performing any work under this  Agreement,  of the Sponsor,
          conceived or first actually  reduced to practice in the course of work
          under this Agreement.

     C.   "Patent Counsel" means the DOE Patent Counsel  assisting the procuring
          activity which has the administrative  responsibility for the facility
          where the work under this Agreement is to be performed.

2. University Inventions.

     The  Government  and the  University  shall  have  rights in any  Invention
     conceived in the  performance  of work under this Agreement by employees of
     the  University in accordance  with the provision of Department of Energy's
     (DOE) Management and Operating (M&O) contract with the University,  subject
     to  the  Sponsor  obtaining  upon  notice  to the  DOE  Patent  Counsel,  a
     nonexclusive,  nontransferable,  irrevocable,  paid-up  license to practice
     said Invention  throughout the world.  Sponsor further has the first option
     to  negotiate  with  the   University   for  an  exclusive   license  in  a
     pre-negotiated field of use on reasonable terms and conditions. This Option
     shall  expire six (6)  months  after the  conclusion  of the work under the
     Statement of Work.

3. Sponsor's Election to Retain Rights.

     Subject to the provisions of 4.B.  (Terms and Conditions of Waived Rights),
     with respect to any Sponsor  Invention  reported and elected in  accordance
     with paragraph 5. (Invention Identification,  Disclosures,  and Reports) of
     this clause,  the Sponsor may elect to obtain the entire right,  title, and
     interest  in any  patent  application  filed in any  country  on a  Sponsor
     Invention,  and in any  resulting  patent  secured  by the  Sponsor.  Where
     appropriate,  the filing of patent application by the Sponsor is subject to
     DOE security regulations and requirements.

4. Rights of University and Government

     A.   Assignment to either the  University or Government  The Sponsor agrees
          to assign to either the University or the Government,  as requested by
          the University,  the entire right,  title, and interest in any country
          to each Sponsor Invention where the Sponsor:

          (1)  does not elect pursuant to this article to retain such rights; or

          (2)  elects  to  obtain  title  to a  Sponsor  Invention  pursuant  to
               paragraph 3  (Sponsor's  Election to Retain  Rights) but fails to
               have a patent  application  filed in that  country on the Sponsor
               Invention, or decides not to continue prosecution,  or not to pay
               any maintenance fees covering the invention; or

          (3)  elects to retain title to a Sponsor Invention but at any time, no
               longer desires to retain title.

     B.   Terms and Conditions of Waived Rights.

          (1)  To preserve the University's and the Government's residual rights
               to Sponsor Inventions, and in patent applications, and patents on
               Sponsor  Inventions,  the  Sponsor  shall  take  all  actions  in
               reporting,  electing,  filing on,  prosecuting,  and  maintaining
               invention rights  promptly,  but in any event, in sufficient time
               to satisfy  domestic and foreign  statutory and  regulatory  time
               requirements,  or, if the Sponsor decides not to take appropriate
               steps to  protect  the  invention  rights,  it shall  notiiy  the
               University or the Goverrunent in sufficient time to permit either
               the University or the Government to file, prosecute, and maintain
               patent  applications,  and any resulting patents prior to the end
               of  such  domestic  or  foreign   statutory  or  regulatory  time
               requirements.

          (2)  The Sponsor shall convey or ensure the conveyance of any executed
               instruments  necessary  to vest in either the  University  or the
               Government the rights set forth in this article.

                                                  Sequentially numbered page 106
<PAGE>


          (3)  With  respect  to any  Sponsor  Invention  in which  the  Sponsor
               obtains  title,  the Sponsor  hereby  grants to the  Government a
               non-exclusive,  nontransferable,  irrevocable, paid-up license to
               practice or have  practiced by or on behalf of the United States,
               the Sponsor Invention throughout the world.

          (4)  The Sponsor  shall  provide the  Government  a copy of any patent
               applications  filed on a Sponsor  Invention within six (6) months
               after such application is filed,  including its serial number and
               filing date.

          (5)  Preference for U.S. Industry. Notwithstanding any other provision
               of  this  article,  the  Sponsor  agrees  that  any  products  or
               processes  embodying the Subject Invention for use or sale in the
               United States, shall be substantially  manufactured in the United
               States,  and that neither it nor any  assignee  will grant to any
               person the exclusive  right to use or sell any Sponsor  Invention
               in the United States, unless such person agrees that any products
               embodying the Sponsor  Invention,  or produced through the use of
               the Sponsor Invention, will be manufactured  substantially in the
               United States.  However, in individual cases, the requirement for
               such an  agreement  may be waived  by DOE upon a  showing  by the
               Sponsor or its assignee that reasonable but unsuccessful  efforts
               have been made to grant  licenses on similar  terms to  potential
               licensees  that would be likely to manufacture  substantially  in
               the  United  States,  or that under the  circumstances,  domestic
               manufacture is not commercially feasible.

          (6)  March-in  Rights.  The Sponsor  agrees  that with  respect to any
               Sponsor Invention,  the DOE shall retain the right to require the
               Sponsor to grant to a  responsible  applicant,  a  non-exclusive,
               partially  exclusive,  or  exclusive  license to use the  Sponsor
               Invention in any field of use, on terms that are reasonable under
               the  circumstances,  or if the  Sponsor  fails  to  grant  such a
               license, to grant the license itself. DOE may exercise this right
               only in  exceptional  circumstances,  and only if DOE  determines
               that:

                    (a)  the action is  necessary to meet health or safety needs
                         that are not reasonably satisfied by the Sponsor, or

                    (b)  the action is  necessary to meet the  requirements  for
                         public use specified by Federal  regulations,  and such
                         requirements  are  not  reasonably   satisfied  by  the
                         Sponsor; or

                    (c)  such  action is  necessary  because a  licensee  of the
                         exclusive right to use or sell any Subject Invention in
                         the  United  States  is in  breach  of  this  Agreement
                         required  by  paragraph  4.B.(5)  (Preference  for U.S.
                         Industry).

          (7)  The  Sponsor  agrees to refund any  amounts  received  as royalty
               charges on any Sponsor  Invention in procurements by or on behalf
               of  the  Government,  and  to  provide  for  that  refund  in any
               instrument transferring rights to any party in the invention.

          (8)  The Sponsor agrees to include,  within the  specification  of any
               United States patent applications, and any patent issuing thereon
               covering  a Sponsor  Invention,  the  following  statement.  "The
               Government has rights in this invention pursuant to "FIA-98-O53."

5. Invention Identification, Disclosures, and Reports.

     A.   The Sponsor shall furnish the Patent Counsel,  and the  University,  a
          written  report  containing  full and complete  technical  information
          concerning each Sponsor Invention it makes within six (6) months after
          conception  or ftrst actual  reduction to practice,  whichever  occurs
          first,  in the  course of or under  this  Agreement,  but in any event
          prior  to any on  sale,  public  use,  or  public  disclosure  of such
          invention known to the Sponsor. The report shall identify the contract
          and inventor,  and shall be sufficiently complete in technical detail,
          and  appropriately  illustrated  by sketch or diagram to convey to one
          skilled  in  the  art  to  which  the   invention   pertains  a  clear
          understanding  to the extent known at the time of  disclosure,  of the
          nature,  purpose,  operation,  and to the extent known,  the physical,
          chemical,  biological, or electrical characteristics of the invention.
          The report should also include any election of invention  rights under
          this article. When an invention is reported under this paragraph 5.A.,
          it shall be  presumed  to have been made in the  manner  specified  in
          Section (a)(l) and (2) of 42 USC 59O8.

                                                  Sequentially numbered page 107
<PAGE>


   B.      The  University  shall  report  University  Inventions  it  makes  in
           accordance  with  the  procedures  set  forth in its  Management  and
           Operating  Contract  with DOE.  In  addition,  the  University  shall
           disclose  to the  Sponsor,  at the  same  time as  disclosure  to the
           Department,  any University  Inventions made by the University  under
           this Agreement.

6. Limitation of Rights

     Nothing contained in this patent rights article shall be deemed to give the
     Government any rights with respect to any invention other than a University
     or  Sponsor  Invention,  except as set forth in the  Facilities  License of
     paragraph 7.

7. Facilities License.

     In addition  to the rights of the Parties  with  respect to  inventions  or
     discoveries  conceived or first actually  reduced to practice in the course
     of or under this Agreement, the Sponsor agrees to, and does hereby grant to
     the Government,  an irrevocable,  non-exclusive,  paid-up license in and to
     any  inventions  or  discoveries  regardless  of when  conceived  or  first
     actually  reduced to  practice,  or acquired by the  Sponsor,  which at any
     time, through completion of this Agreement,  are owned or controlled by the
     Sponsor,  and  are  incorporated  in  the  Facility  as a  result  of  this
     Agreement,  to such an extent  that the  Facility  is not  restored  to the
     condition  existing  prior to this  Agreement  (1) to  practice  or to have
     practiced by or for the  Government  at the  Facility,  and (2) to transfer
     such license with the transfer of the Facility.  The acceptance or exercise
     by the Government of the aforesaid rights and license shall not prevent the
     Government at any time from  contesting the  enforceability,  validity,  or
     scope of, or title to any rights or patents herein licensed.

8. Early Termination of Agreement.

     The terms and conditions of this article shall survive this Agreement, even
     in the event that this  Agreement is  terminated  before  completion of the
     Statement of Work.

                                                  Sequentially numbered page 108
<PAGE>


                                   APPENDIX C
            RIGHTS IN TECHNICAL DATA - USE OF FACILITIES (UNLIMITED)


The  Sponsor,  University,  and the  Government,  shall  have the  right to use,
disclose,  and duplicate for any purpose whatsoever,  and have others do so, all
technical  data first  produced  or used in the  performance  of work under this
Agreement, (Technical data is defined as set forth in 48 CFR 27.401).

Any Sponsor furnished, properly marked Proprietary Information necessary for, or
pertaining  to work under this  Agreement,  will not be  disclosed  outside  the
Government  or  University,  and will be  returned  to the  Sponsor by or before
termination of this Agreement.


                                                  Sequentially numbered page 109
<PAGE>


                                          LANL Document Control No.  99-42-00558



                                   APPENDIX D





                                   MILESTONES

1.   Licensee  will enter into a research  and  development  agreement  with the
     Univesity  that will lead to the  reduction  to practice  of the  invention
     described in U.S.  Provisional  Patent  Application  AN 60/113,139  (PATENT
     RIGHTS)  and to the  delivery to the  Licensee  of a  prototype  instrument
     embodying this invention at the end of that agreement.

2.   Complete  survey to  identify  strategic  partners  for  manufacturing  and
     distribution  and  deliver a report to the  University  within  120 days of
     delivery of the prototype instrument.

3.   Complete a draft  marketing plan and deliver to the  University  within six
     (6) months of delivery of the prototype instrument.

4.   Complete alpha testing of the prototype  instrument and deliver a report to
     the  University  within  twelve (12)  months of  delivery of the  prototype
     instrument.

5.   Complete beta testing of the prototype  instrument  and deliver a report to
     the  University  within  eighteen  (18) months of delivery of the prototype
     instrument.


FINAL DRAFT 2/18/99                                                      Page 20
                                                  Sequentially numbered page 110
<PAGE>


                                   APPENDIX E


                                  REPORT FORMAT
Date of Report:
Reporting Period:
Corporate Fiscal Year Is:

1.       DEVELOPMENT:

         -Progress towards commercialization
         -Problems encountered
         -Pre-commercialization marketing efforts
         -Any shift in time-line from original business plan
         -Expected launch date
         -Any improvements, new patents, derivative works, etc. arising from the
          work

2.       COMMERCIALIZATION:

         -First commercial sale
         -Sales, production or other royalty-generating activity
         -Royalty calculations and royalties due

3.       CONTINUING:

         -Continued  efforts  in  evolving  the  product/service
         -Improvements
         -Sublicenses
         -Foreign registrations, licenses, commercialization,  etc.
         -Any problems which would potentially effect the License Agreement
         -Any infringements of intellectual property (as provided in the License
          Agreement)
         -Any potential litigation involving the licensed intellectual property

4.       OF GENERAL INTEREST:

         -Promotional  material,  news releases,  etc.
         -Company  annual reports
         -Testing activity,  scientific publications
         -Any feedback,  positive or negative
         -Suggestions


FINAL DRAFT 2/18/99                                                      Page 21
                                                  Sequentially numbered page 111
<PAGE>


                                   APPENDIX F


                             FINANCIAL REPORT FORMAT

Date of Report:

Reporting Period:

Corporate Fiscal Year is:

<TABLE>
<CAPTION>

Domestic Sales
          <S>                <C>               <C>              <C>             <C>              <C>               <C>

------------------- ---------------------- ------------- ----------------- --------------- --------------- --------------------
  Description of      Unit Price (sale                                     Gross sales
     Licensed        lease, and/or use)     Units sold     Units leased    in U.S.         Net Sales in    Royalties due in $
    Product(s)                                                                             U.S.                   U.S.
------------------- ---------------------- ------------- ----------------- --------------- --------------- --------------------



















------------------- ---------------------- ------------- ----------------- --------------- --------------- --------------------

</TABLE>

FINAL DRAFT 2/18/99                                                      Page 22
                                                  Sequentially numbered page 112
<PAGE>


<TABLE>
<CAPTION>


Foreign Sales By Country
       <S>            <C>             <C>          <C>        <C>          <C>         <C>            <C>            <C>

--------------- -------------- --------------- ---------- ------------ ----------- ------------ --------------- ---------------
   Country       Description     Unit Price                            Gross                       Monetary
                     of        (sale, lease,    Units        Units     sales in    Net Sales    exchange rate   Royalties due
                  Licensed      and/or use)      Sold       leased     U.S.        in U.S.                        in $ U.S.
                 Product(s)
--------------- -------------- --------------- ---------- ------------ ----------- ------------ --------------- ---------------
















--------------- -------------- --------------- ---------- ------------ ----------- ------------ --------------- ---------------

</TABLE>

<TABLE>
<CAPTION>

U.S. Government Sales
         <S>                    <C>               <C>               <C>                 <C>                    <C>

---------------------- --------------------- -------------- --------------------- ------------------ --------------------------
   Description of       Unit Price (sale,                                         Gross sales to
 Licensed Product(s)    lease, and/or use)    Units Sold      Units leased to     U.S. Govt.         Net Sales to U.S. Govt.
                                             to U.S. Govt.       U.S. Govt.
---------------------- --------------------- -------------- --------------------- ------------------ --------------------------
















---------------------- --------------------- -------------- --------------------- ------------------ --------------------------

</TABLE>

FINAL DRAFT 2/18/99                                                      Page 23
                                                  Sequentially numbered page 113
<PAGE>


                                   APPENDIX G


                        DESIGNATION OF THE LICENSING TEAM


Negotiating Team:

John B. Mott, Licensing Executive
Civilian & Industrial Technology Program Office

Pay G. Wilson, Patent Attorney
Business & Patent Law

Sandra Zink, Bioscience Program Manager
Civilian & Industrial Technology Program Office

Technical Advisors:

Alonso Castro, Technical Staff Member, P-21
Chris Wood, Group Leader, P-21


FINAL DRAFT 2/18/99                                                      Page 24

                                                  Sequentially numbered page 114


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission